Incorporating ctDNA, Novel Therapies Into Practice for Colorectal Cancer

A roundtable discussion, moderated by Shikha Jain, MD, FACP, discussed the treatment sequencing, management, and future directions of advanced colorectal cancer, as well as relevant clinical trial data from the 2024 American Society of Clinical Oncology Annual Meeting. Dr. Jain was joined by Suneel Kamath, MD; Arvind Dasari, MD, MS; and Sakti Chakrabarti, MD.
In the fourth segment of the roundtable series, the panel expands on the incorporation of ctDNA in the adjuvant setting for colorectal cancer, highlighting its prognostic value and application. Together, they also review the impact and tolerability of the FRESCO and FRESCO-2 trials on clinical practice.